The Lancet. Neurology Journal

Overview
Identity
View All

publication venue for

Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.. 23:1013-1024. 2024
Concerns with the new biological research criteria for synucleinopathy.. 23:659-660. 2024
MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.. 23:487-499. 2024
A chance to prevent Alzheimer's disease sooner than you think.. 23:144-145. 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis.. 23:168-177. 2024
Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation.. 21:153-162. 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.. 21:140-152. 2022
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.. 20:795-820. 2021
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.. 20:537-547. 2021
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.. 20:484-496. 2021
New insights into atypical Alzheimer's disease in the era of biomarkers.. 20:222-234. 2021
The necessity of diplomacy in brain health.. 19:972-974. 2020
Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.. 19:899-907. 2020
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.. 19:502-512. 2020
Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study.. 18:953-961. 2019
Association between circadian rhythms and neurodegenerative diseases.. 18:307-318. 2019
Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.. 17:773-781. 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.. 17:241-250. 2018
Challenges ahead for trials in Friedreich's ataxia.. 15:1300-1301. 2016
Research priorities to reduce the global burden of dementia by 2025.. 15:1285-1294. 2016
Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.. 15:811-819. 2016
Defeating Alzheimer's disease and other dementias: a priority for European science and society.. 15:455-532. 2016
The epidemiology of Parkinson's disease: risk factors and prevention.. 15:1257-1272. 2016
The interface between delirium and dementia in elderly adults.. 14:823-832. 2015
Friedreich's ataxia: the European consortium.. 14:130-1. 2015
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.. 14:153-61. 2014
Connections between sleep and cognition in older adults.. 13:1017-28. 2014
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.. 13:788-94. 2014
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.. 13:614-29. 2014
Neurological complications of cardiac surgery.. 13:490-502. 2014
Urate and neuroprotection trials.. 13:-. 2014
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.. 13:167-77. 2013
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.. 12:957-65. 2013
Traumatic brain injury and neuropsychiatric outcomes.. 11:1020-1. 2012
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.. 11:1048-56. 2012
Cognitive reserve in ageing and Alzheimer's disease.. 11:1006-12. 2012
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.. 11:241-9. 2012
Dementia: new criteria but no new treatments.. 11:4-5. 2012
The projected effect of risk factor reduction on Alzheimer's disease prevalence.. 10:819-28. 2011
Apolipoprotein E in Alzheimer's disease and other neurological disorders.. 10:241-52. 2011
Revising the definition of Alzheimer's disease: a new lexicon.. 9:1118-27. 2010
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.. 7:1091-8. 2008
Non-autonomous cell death in Parkinson's disease.. 7:474-5. 2008
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.. 6:734-46. 2007
Testosterone and the brain: uncharted territory.. 3:-. 2004